Clinical Trial Update: Testing Low Dose Tamoxifen for Invasive Breast Cancer, the (LoTam) Trial [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating low-dose tamoxifen for invasive breast cancer (LoTam) has been suspended. Sponsored by the Alliance for Clinical Trials in Oncology, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage 1 Breast Cancer AJCC v8 | Phase 3 | Status: SUSPENDED